Search research articles
Contact Us
Filters
Showing results (21-30 of 186) with videos related to
Page
of 19
Sort By:
Rheumatology Advances in Practice
|
August 1, 2022
A curious case of granulomatosis with polyangiitis: prostatic and skin involvement
Laura Trives-Folguera, David Isenberg
Lupus
|
March 29, 2008
Therapeutic potential (1)
Debra Jeske Zack, David Isenberg
Rheumatology (Oxford, England)
|
August 24, 2016
Kidney disease in primary anti-phospholipid antibody syndrome
Borja Gracia-Tello, David Isenberg
Expert Opinion on Pharmacotherapy
|
September 13, 2018
An evaluation of voclosporin for the treatment of lupus nephritis
Fang En Sin, David Isenberg
Frontiers in Medicine
|
June 2, 2022
Differences in the Development of Adverse Infusion Reactions to Rituximab in Patients With Systemic Lupus Erythematosus, Rheumatoid Arthritis and Non-Hodgkin's Lymphoma-Enigma Variations
Sergio Gilaberte Reyzabal, David Isenberg
Lupus
|
January 21, 2021
Analysis of trends and causes of death in SLE patients over a 40-years period in a cohort of patients in the United Kingdom
Ana Lorenzo-Vizcaya, David Isenberg
Rheumatology (Oxford, England)
|
September 15, 2022
The use of combination monoclonal antibody therapies in lupus-where are we now?
Joana Rua, Maria Dall'Era, David Isenberg
Arthritis Research & Therapy
|
June 8, 2004
B cell depletion in autoimmune disease
Claire Gorman, Maria Leandro, David Isenberg
Expert Review of Clinical Immunology
|
November 15, 2016
Improving B-cell depletion in systemic lupus erythematosus and rheumatoid arthritis
Pedro Mota, Venkat Reddy, David Isenberg
Expert Opinion on Pharmacotherapy
|
April 20, 2025
Challenges of anticoagulation in patients with systemic lupus erythematosus
Luigi Zolio, Hannah Cohen, David Isenberg
Page
of 19
Search research articles
Search
Showing results (21-30 of 186) with videos related to
Sort By:
Page
of 19
Rheumatology Advances in Practice
|
August 1, 2022
A curious case of granulomatosis with polyangiitis: prostatic and skin involvement
Laura Trives-Folguera, David Isenberg
Lupus
|
March 29, 2008
Therapeutic potential (1)
Debra Jeske Zack, David Isenberg
Rheumatology (Oxford, England)
|
August 24, 2016
Kidney disease in primary anti-phospholipid antibody syndrome
Borja Gracia-Tello, David Isenberg
Expert Opinion on Pharmacotherapy
|
September 13, 2018
An evaluation of voclosporin for the treatment of lupus nephritis
Fang En Sin, David Isenberg
Frontiers in Medicine
|
June 2, 2022
Differences in the Development of Adverse Infusion Reactions to Rituximab in Patients With Systemic Lupus Erythematosus, Rheumatoid Arthritis and Non-Hodgkin's Lymphoma-Enigma Variations
Sergio Gilaberte Reyzabal, David Isenberg
Lupus
|
January 21, 2021
Analysis of trends and causes of death in SLE patients over a 40-years period in a cohort of patients in the United Kingdom
Ana Lorenzo-Vizcaya, David Isenberg
Rheumatology (Oxford, England)
|
September 15, 2022
The use of combination monoclonal antibody therapies in lupus-where are we now?
Joana Rua, Maria Dall'Era, David Isenberg
Arthritis Research & Therapy
|
June 8, 2004
B cell depletion in autoimmune disease
Claire Gorman, Maria Leandro, David Isenberg
Expert Review of Clinical Immunology
|
November 15, 2016
Improving B-cell depletion in systemic lupus erythematosus and rheumatoid arthritis
Pedro Mota, Venkat Reddy, David Isenberg
Expert Opinion on Pharmacotherapy
|
April 20, 2025
Challenges of anticoagulation in patients with systemic lupus erythematosus
Luigi Zolio, Hannah Cohen, David Isenberg
Page
of 19